Recent research is producing new treatment approaches for multiple myeloma — giving physicians and patients more options to manage this deadly blood cancer. We heard encouraging news at the 2009 American Society of Hematologists annual meeting. Dr. Harish Dave and Dr. Ben Manderman, respected experts in hematology and oncology, give an overview of the latest studies into novel drug combinations and new therapies in early stage testing.